Former GW Pharmaceuticals Advisor Discusses The Future of Medical Cannabis with Ganjapreneur.com

Share Article

The latest podcast from Ganjapreneur.com features prominent medical marijuana researcher Dr. Ethan Russo in a conversation about Endocannabinoid Deficiency and how it can be treated with medical cannabis.

Dr. Ethan Russo

A lot of what THC does is paralleled by the effects of natural chemicals in the body that everyone has.

Cannabis business website Ganjapreneur has announced its latest podcast episode, which features prominent medical marijuana researcher Dr. Ethan Russo in a conversation about his research regarding the Endocannabinoid System — a unique system found in all vertebrates, including humans, which promotes homeostasis and a biological balance across bodily functions.

In the interview, Ganjapreneur podcast host Shango Los asks Dr. Russo about Endocannabinoid Deficiency (ECD) and the potential for it to be treated with cannabis. As Russo explains, ECD is just coming into general awareness now as a cause behind several conditions including Migraines, Fibromyalgia, Irritable Bowel Syndrome, Phantom Limb Pain, Infantile colic, Glaucoma, PTSD, Bipolar disease and others.

When used as a form of treatment, "A lot of what THC does is paralleled by the effects of... natural chemicals in the body that everyone has," Dr. Russo explains.

Before going public with his research, Dr. Russo worked for years as Senior Medical Adviser for GW Pharmaceuticals; there, he oversaw three separate clinical trials for Sativex, one of the world's first cannabinoid-based medicines to be approved for public use. Today, he is Medical Director at Phytecs, a company specializing in the production of cannabis-based treatments related to the endocannabinoid system. Due to legal complications and concerns over the federal legality of his work, Dr. Russo only began to speak publicly about his research earlier this year.

The full podcast is available via iTunes and on Ganjapreneur's website.

About Ganjapreneur:
Ganjapreneur launched in July 2014 and has since established a significant presence in the cannabis business world. The website regularly publishes interviews and commentary from leading minds in the industry, and has also launched a B2B business directory, a live feed of job listings from marijuana job boards, a domain name marketplace for start-ups and venture capital firms, and a mobile app for Apple and Android devices which aggregates daily cannabis industry news, business profiles, and other information.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Graham Abbott
Ganjapreneur
360 525 3563
Email >
Follow us on
Visit website